MONA CHIURILLO: Open Payments
NPI 1053833475 · PLANTSVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 43 payments from 9 companies in 2025. Trend: 2023 $890 · 2024 $81 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $208 |
| Collegium Pharmaceutical, Inc. | 9 | $157 |
| Corium, LLC | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: VRAYLAR, Jornay PM, Azstarys, CAPLYTA, Qelbree, REXULTI, INGREZZA, FANAPT.
Industry payments across CT — which companies pay providers there.
